CNM-Au8

N/A

Report date: 2023/12/22 10:11:45

Base Information

Drug NameCNM-Au8
Drug Alias NameNanocrystalline goldGold nanocrystal suspension
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDemyelinating DiseasesOptic Nerve DiseasesAmyotrophic Lateral Sclerosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesClene Nanomedicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesClene Australia Pty LtdClene Nanomedicine Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseMultiple Sclerosis
Inactive IndicationsDemyelinating DiseasesOptic Nerve DiseasesMultiple Sclerosis, Relapsing-Remitting

Other Information

ATC CodeN/A
Related LinksN/A